HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gluck, M. R. Articles by Nicklas, W. J. Search for Related Content PubMed PubMed Citation Articles by Gluck, M. R. Articles by Nicklas, W. J. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 269, Issue 5, 3167-3174, 02, 1994

Characterization of the inhibitory mechanism of 1-methyl-4- phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparations

MR Gluck, MJ Krueger, RR Ramsay, SO Sablin, TP Singer and WJ Nicklas
Department of Neurology, University of Medicine and Dentistry New Jersey-Robert Wood Johnson Medical School, Piscataway 08854-5635.

We have investigated the mechanism of the inhibition of membrane-bound NADH dehydrogenase by 1-methyl-4-phenylpyridinium (MPP+) and a series of its 4'-alkyl-substituted analogs of increasing hydrophobicity, as well as their neutral, desmethyl congeners. Comparison of hydrophobicity, as measured by partition coefficients, with the IC50 for the inhibition of NADH oxidase activity in mitochondrial inner membrane preparations shows a negative correlation, but the cationic inhibitors are more effective than the neutral analogs with similar hydrophobicity. The presence of 10 microM tetraphenylboron (TPB-) potentiates the inhibitory power of positively charged analogs up to 4'- pentyl-MPP+, while the neutral inhibitors are unaffected by TPB-. Without TPB-, the more hydrophilic analogs give incomplete inhibition, but the inclusion of TPB- permits the attainment of complete inhibition, accompanied by the appearance of sigmoidal titration curves. These data support the hypothesis that MPP+ analogs, like rotenone, are bound at two sites on the enzyme and occupancy of both is required for complete inhibition. TPB-, by forming ion pairs with the cationic analogs, facilitates their equilibration to both sites in membrane preparations. When present in molar excess over the MPP+ analog, TPB- partially reverses the inhibition by decreasing its concentration in the more hydrophilic binding site. The effect of temperature and of pH on the IC50 values for inhibition support the concept of dual binding sites, and the pH dependence of the inhibition reveals the participation of two ionized protein groups in the binding, one of which may be a thiol group.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Doostzadeh, R. W. Davis, G. N. Giaever, C. Nislow, and J. W. Langston Chemical Genomic Profiling for Identifying Intracellular Targets of Toxicants Producing Parkinson's Disease Toxicol. Sci., January 1, 2007; 95(1): 182 - 187. [Abstract] [Full Text] [PDF]

				Y. Kashiwaya, T. Takeshima, N. Mori, K. Nakashima, K. Clarke, and R. L. Veech D-beta -Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease PNAS, May 9, 2000; 97(10): 5440 - 5444. [Abstract] [Full Text] [PDF]

				F. Schuler, T. Yano, S. Di Bernardo, T. Yagi, V. Yankovskaya, T. P. Singer, and J. E. Casida NADH-quinone oxidoreductase: PSST subunit couples electron transfer from iron-sulfur cluster N2 to quinone PNAS, March 30, 1999; 96(7): 4149 - 4153. [Abstract] [Full Text] [PDF]

				J. Lotharius, L. L. Dugan, and K. L. O'Malley Distinct Mechanisms Underlie Neurotoxin-Mediated Cell Death in Cultured Dopaminergic Neurons J. Neurosci., February 15, 1999; 19(4): 1284 - 1293. [Abstract] [Full Text] [PDF]

				J. V. BONVENTRE The 85-kD Cytosolic Phospholipase A2 Knockout Mouse: A NewTool for Physiology and Cell Biology J. Am. Soc. Nephrol., February 1, 1999; 10(2): 404 - 412. [Full Text]

				H. Miyoshi, J. Iwata, K. Sakamoto, H. Furukawa, M. Takada, H. Iwamura, T. Watanabe, and Y. Kodama Specificity of Pyridinium Inhibitors of the Ubiquinone Reduction Sites in Mitochondrial Complex I J. Biol. Chem., July 10, 1998; 273(28): 17368 - 17374. [Abstract] [Full Text] [PDF]

				H. Miyoshi, M. Inoue, S. Okamoto, M. Ohshima, K. Sakamoto, and H. Iwamura Probing the Ubiquinone Reduction Site of Mitochondrial Complex I Using Novel Cationic Inhibitors J. Biol. Chem., June 27, 1997; 272(26): 16176 - 16183. [Abstract] [Full Text] [PDF]

				J. Lotharius and K. L. O'Malley The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation. A NOVEL MECHANISM OF TOXICITY J. Biol. Chem., December 1, 2000; 275(49): 38581 - 38588. [Abstract] [Full Text] [PDF]